1. NICE Says No to Inhaled Insulin: What Lessons Should We Learn?

   • Nick Freemantle

   Editorial 09 October 2012 Pages: 627 - 629

2. Economic Models of Antiretroviral Therapy

   • Fred J. Hellinger

   Current Opinion 09 October 2012 Pages: 631 - 642

3. Developing Health-Related Quality-of-Life Instruments for Use in Asia

   • Yin Bun Cheung
   • Julian Thumboo

   Current Opinion 09 October 2012 Pages: 643 - 650

   

4. Cost of Lung Cancer

   • Laurent Molinier
   • Christophe Combescure
   • Alain Vergnenègre

   Review Article 09 October 2012 Pages: 651 - 659

   

5. Hepatitis C

   • John B. Wong

   Review Article 09 October 2012 Pages: 661 - 672

   

6. Usefulness of the Audit of Diabetes-Dependent Quality-of-Life (ADDQoL) Questionnaire in Patients with Diabetes in a Multi-Ethnic Asian Country

   • Hwee-Lin Wee
   • Chee-Eng Tan
   • Shu-Chuen Li

   Original Research Article 09 October 2012 Pages: 673 - 682

   

7. Tapering Off Benzodiazepines in Long-Term Users

   • Richard C. Oude Voshaar
   • Paul F. M. Krabbe
   • Frans G. Zitman

   Original Research Article 09 October 2012 Pages: 683 - 694

   

8. Cost Effectiveness of Budesonide/Formoterol for Maintenance and Reliever Therapy versus Salmeterol/ Fluticasone plus Salbutamol in the Treatment of Asthma

   • Gunnar Johansson
   • Emma B. Andreasson
   • Claus F. Vogelmeier

   Original Research Article 09 October 2012 Pages: 695 - 708

   

9. Clopidogrel

   • Katherine A. Lyseng-Williamson
   • Greg L. Plosker

   Adis Pharmacoeconomic Drug Evaluation 09 October 2012 Pages: 709 - 726